Ceronapril
| |
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C30H46NO7P |
Molar mass | 563.663 g/mol |
3D model (JSmol) | |
| |
|
Ceronapril (INN,[1] proposed trade names Ceranapril, Novopril) in a phosphonate ACE inhibitor[2] that was never marketed.
References
- ↑ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 31" (PDF). World Health Organization. p. 4. Retrieved 2 March 2017.
- ↑ Tu, JI; Brennan, J; Stouffer, B; Mantha, S; Turabi, N; Tsay, HM (June 1992). "Radioimmunoassay for Ceronapril, a New Angiotensin-Converting Enzyme Inhibitor, and Its Application to a Pharmacokinetic Study in Healthy Male Volunteers". Therapeutic Drug Monitoring. 14 (3): 209–19. PMID 1412607.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.